AstraZeneca reported 6.33B in Cash and Equivalent for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Alcon AG ALC:SW 1.58B 10M
AstraZeneca AZN:LN 6329M 738M
Bayer BAYN:GR € 4564M 248M
Fresenius FRE:GR € 2764M 351M
Genmab GEN:DC DK 9071M 114M
GRIFOLS GRF:SM € 397.86M 16.88M
Hikma Pharmaceutical HIK:LN 426M 424M
Lonza Group LONN:SW 1.58B 1.08B
Novartis NOVN:VX SF 12407M 5196M
Orion ORNBV:FH € 216.7M 60.4M
Philips PHIA:NA € 2303M 1524M
Recordati REC:IM € 341.93M 70.06M